PortfoliosLab logo

Cara Therapeutics, Inc.

CARA
Equity · Currency in USD
Sector
Healthcare
Industry
Biotechnology
ISIN
US1407551092
CUSIP
140755109

CARAPrice Chart


Chart placeholderClick Calculate to get results

CARAPerformance

The chart shows the growth of $10,000 invested in Cara Therapeutics, Inc. on Feb 3, 2014 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $9,837 for a total return of roughly -1.63%. All prices are adjusted for splits and dividends.


CARA (Cara Therapeutics, Inc.)
Benchmark (S&P 500)

CARAReturns in periods

Returns over 1 year are annualized

PeriodReturn
1M-18.59%
6M-53.19%
YTD-16.06%
1Y-10.12%
5Y9.94%
10Y-0.21%

CARAMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

CARASharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Cara Therapeutics, Inc. Sharpe ratio is -0.17. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


CARA (Cara Therapeutics, Inc.)
Benchmark (S&P 500)

CARADividends


Cara Therapeutics, Inc. doesn't pay dividends

CARADrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


CARA (Cara Therapeutics, Inc.)
Benchmark (S&P 500)

CARAWorst Drawdowns

The table below shows the maximum drawdowns of the Cara Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Cara Therapeutics, Inc. is 80.50%, recorded on Jun 27, 2016. It took 251 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-80.5%Aug 6, 2015225Jun 27, 2016251Jun 26, 2017476
-66.16%Jun 29, 2017684Mar 18, 2020264Apr 6, 2021948
-65.5%Mar 6, 2014161Oct 22, 2014197Aug 5, 2015358
-60.43%Apr 12, 202181Aug 4, 2021
-17.89%Feb 3, 20143Feb 5, 20143Feb 10, 20146
-4.33%Feb 19, 20141Feb 19, 20141Feb 20, 20142
-3.87%Feb 11, 20141Feb 11, 20144Feb 18, 20145
-3.47%Feb 24, 20141Feb 24, 20142Feb 26, 20143
-2.28%Apr 7, 20211Apr 7, 20211Apr 8, 20212

CARAVolatility Chart

Current Cara Therapeutics, Inc. volatility is 25.73%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


CARA (Cara Therapeutics, Inc.)
Benchmark (S&P 500)

Portfolios with Cara Therapeutics, Inc.


Loading data...

More Tools for Cara Therapeutics, Inc.